Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1603466 STAMFORD, CT
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$411,158
-$4,302,074 QoQ
Shares Held
134,806
-87.1% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 162 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. LRMR ranks #129 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 4,473,478 $158,316,386
2 CYTK
Cytokinetics Inc
 1,587,712 $135,257,185
3 BBIO
BridgeBio Pharma, Inc.
 1,525,782 $113,640,243
4 AXSM
Axsome Therapeutics, Inc.
 416,516 $101,950,621
5 LEGN
Legend Biotech Corp
 3,076,124 $88,838,461
6 MDGL
Madrigal Pharmaceuticals, Inc.
 137,029 $73,577,721
7 CELC
Celcuity Inc.
 650,916 $68,098,831
8 ACAD
Acadia Pharmaceuticals Inc
 2,433,168 $61,559,150

All Filings in LRMR

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $411,158 134,806
2026-03-31 $4,713,232 1,047,385
2025-12-31 $5,566,516 1,461,028
2025-09-30 $3,953,087 1,223,866
2024-09-30 $1,356,505 207,100
2024-06-30 $4,375,962 603,581
2024-03-31 $3,327,456 438,400
2023-12-31 $2,049,320 450,400
2023-09-30 $1,797,250 455,000
2023-06-30 $2,626,070 839,000
2023-03-31 $2,061,150 455,000
2022-12-31 $1,961,750 475,000
2022-09-30 $1,520,000 475,000
2021-12-31 $2,124,507 196,896
2021-09-30 $2,270,210 196,896
2021-06-30 $973,751 99,160
2021-03-31 $252,168 17,260
2020-12-31 $369,536 17,260
2020-09-30 $261,834 17,260
2020-06-30 $221,791 17,260